TM
6 Feb 2024
BariaTek Medical Announces the First-in-Human Implantation of Its BariTon™ Device, a Non-Surgical Gastro-Intestinal Medical Device Aiming to Replicate the Efficacy of Obesity Surgery Without the Invasiveness
We are happy to announce that we have started enrolling patients in our first-in-human clinical trial in Australia and Uzbekistan. The first patient was treated two weeks ago, she went back to work the day after her discharge from the endoscopic procedure during which the BariTon™ was implanted.
Although this is a great milestone, we are both humbled and thrilled by the exciting and hard work that is still ahead of us before we can bring our highly differentiated solution, the BariTon™, to BOTH gastroenterologists and surgeons, and to patients worldwide.